These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31192324)
21. Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates. Kundel F; Tosatto L; Whiten DR; Wirthensohn DC; Horrocks MH; Klenerman D FEBS J; 2018 Oct; 285(19):3604-3630. PubMed ID: 29453901 [TBL] [Abstract][Full Text] [Related]
22. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases. Cremades N; Dobson CM Neurobiol Dis; 2018 Jan; 109(Pt B):178-190. PubMed ID: 28709995 [TBL] [Abstract][Full Text] [Related]
23. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line. Ruiz ED; Almada M; Burboa MG; Taboada P; Mosquera V; Valdez MA; Juárez J Colloids Surf B Biointerfaces; 2015 Feb; 126():335-43. PubMed ID: 25618793 [TBL] [Abstract][Full Text] [Related]
24. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities. Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507 [TBL] [Abstract][Full Text] [Related]
25. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation. van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973 [TBL] [Abstract][Full Text] [Related]
26. Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions. Cieplak AS PLoS One; 2017; 12(9):e0180905. PubMed ID: 28922400 [TBL] [Abstract][Full Text] [Related]
27. Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation. Song Y; Li P; Liu L; Bortolini C; Dong M Sci Rep; 2018 Jan; 8(1):765. PubMed ID: 29335442 [TBL] [Abstract][Full Text] [Related]
28. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases. Choi ML; Gandhi S FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502 [TBL] [Abstract][Full Text] [Related]
29. Bis(indolyl)phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme. Ramshini H; Mannini B; Khodayari K; Ebrahim-Habibi A; Moghaddasi AS; Tayebee R; Chiti F Eur J Med Chem; 2016 Nov; 124():361-371. PubMed ID: 27597412 [TBL] [Abstract][Full Text] [Related]
30. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation. Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644 [TBL] [Abstract][Full Text] [Related]
31. When proteostasis goes bad: Protein aggregation in the cell. Radwan M; Wood RJ; Sui X; Hatters DM IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs. Fortin JS; Benoit-Biancamano MO Can J Physiol Pharmacol; 2016 Jan; 94(1):35-48. PubMed ID: 26524404 [TBL] [Abstract][Full Text] [Related]
33. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation. Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297 [TBL] [Abstract][Full Text] [Related]
34. Assessment of the effect of macromolecular crowding on aggregation behaviour of a model amyloidogenic Peptide. Gaharwar B; Gour S; Kaushik V; Gupta N; Kumar V; Hause G; Yadav JK Protein Pept Lett; 2015; 22(1):87-93. PubMed ID: 25267253 [TBL] [Abstract][Full Text] [Related]
35. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis. Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517 [TBL] [Abstract][Full Text] [Related]
36. Prion-Like Protein Aggregates and Type 2 Diabetes. Mukherjee A; Soto C Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831 [TBL] [Abstract][Full Text] [Related]
37. A minimal conformational switching-dependent model for amyloid self-assembly. Ranganathan S; Ghosh D; Maji SK; Padinhateeri R Sci Rep; 2016 Feb; 6():21103. PubMed ID: 26883720 [TBL] [Abstract][Full Text] [Related]
38. Regulation of the aggregation behavior of human islet amyloid polypeptide fragment by titanocene complexes. Du W; Gong G; Wang W; Xu J J Biol Inorg Chem; 2017 Oct; 22(7):1065-1074. PubMed ID: 28801867 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules. Brahmachari S; Paul A; Segal D; Gazit E Future Med Chem; 2017 May; 9(8):797-810. PubMed ID: 28485623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]